首页> 外文期刊>Cerebrovascular Diseases Extra >Endovascular Stroke Therapy Results Improve over Time: The ‘Learning Curve' at a New Comprehensive Stoke Center
【24h】

Endovascular Stroke Therapy Results Improve over Time: The ‘Learning Curve' at a New Comprehensive Stoke Center

机译:血管内卒中治疗结果随时间而改善:新的综合性卒中中心的“学习曲线”

获取原文
           

摘要

Background: The requirements for a comprehensive stroke center (CSC) include the capability to perform endovascular stroke therapy (EST). EST is a complex process requiring early identification of appropriate patients and effective delivery of intervention. In order to provide prompt intervention for stroke, CSCs have been established away from large academic centers in community-based hospitals. We hypothesized that quantifiable improvements would occur during the first 2 years of a community-based CSC as the processes and personnel evolved. We report the results over time of EST at a new community-based CSC. Methods: We have retrospectively analyzed demographic data and outcome metrics of EST from the initiation phase of a new community-based CSC. Data was divided into year 1 and year 2. Statistical analysis (Student's t test and Fisher's exact test) was performed to compare the patient population and outcomes across the two time periods. Outcome variables included the thrombolysis in cerebral infarction (TICI) score, a change in the NIH stroke scale score and the modified Rankin Scale (mRS) score. Analysis of variance (ANOVA) was used to statistically analyze the relationship between population variables and outcome. Computed tomography (CT) angiography and CT perfusion analysis were used to select patients for EST. Approximately half of the patients undergoing EST were excluded from receiving intravenous recombinant tissue plasminogen activator (IV rt-PA) by standard criteria, while the other half showed no sign of improvement following 1 h of IV rt-PA treatment. Mechanical thrombolysis with a stentriever was performed in the majority of cases with or without intra-arterial medication. The majority of treated occlusions were in the middle cerebral artery. Results: A total of 18 patients underwent EST during year 1 and year 2. A statistically significant increase in good outcomes (mRS score ≤2 at discharge) was seen from year 1 to year 2 (p = 0.05). There were trends towards faster interventions, decreased complications and mortality as well as an improved TICI score from year 1 to year 2. With ANOVA, mortality was statistically correlated with age (p = 0.06), while decreases in the NIH stroke scale (NIHSS) score following EST correlated with decreased mortality (p = 0.01). A higher TICI score was significantly associated with a decreased NIHSS score following EST (p = 0.01). Conclusions: At a new community-based CSC, improved outcome occurred from year 1 to year 2, and trends towards decreased mortality, fewer complications, and improved revascularization were observed. Furthermore, the data shows that improvement in NIHSS score after EST is associated with decreased mortality following stroke in this setting, implying a net benefit.
机译:背景:对综合性卒中中心(CSC)的要求包括进行血管内卒中治疗(EST)的能力。 EST是一个复杂的过程,需要及早发现合适的患者并有效地进行干预。为了提供对中风的及时干预,已经在社区医院的大型学术中心附近建立了CSC。我们假设随着流程和人员的发展,在基于社区的CSC的前两年内将发生可量化的改进。我们在新的基于社区的CSC上报告了EST在一段时间内的结果。方法:从新的基于社区的CSC的启动阶段开始,我们回顾性分析了EST的人口统计数据和结果指标。数据分为第一年和第二年。进行统计分析(学生t检验和费舍尔精确检验)以比较两个时期的患者人数和结果。结果变量包括脑梗塞溶栓(TICI)评分,NIH中风量表评分的变化和改良的Rankin量表(mRS)评分。方差分析(ANOVA)用于统计分析人口变量与结果之间的关系。计算机断层扫描(CT)血管造影和CT灌注分析用于选择EST患者。根据标准标准,大约一半接受EST的患者不接受静脉内重组组织纤溶酶原激活剂(IV rt-PA),而另一半在接受IV rt-PA治疗1小时后未见改善迹象。在大多数有或没有动脉内药物治疗的情况下,均使用支架支架进行机械溶栓。接受治疗的大多数阻塞位于大脑中动脉。结果:在第1年和第2年,共有18例患者接受了EST。从第1年到第2年,观察到良好的预后(出院时mRS得分≤2)有统计学意义的提高(p = 0.05)。从第1年到第2年,趋势是采取更快的干预措施,减少并发症和降低死亡率以及改善TICI评分。通过ANOVA,死亡率在统计学上与年龄相关(p = 0.06),而NIH中风量表(NIHSS)有所降低EST后的评分与死亡率降低相关(p = 0.01)。较高的TICI分数与EST后NIHSS分数降低显着相关(p = 0.01)。结论:在一个新的基于社区的CSC中,从第1年到第2年的结局有所改善,并且观察到死亡率降低,并发症减少和血运重建改善的趋势。此外,数据显示,在这种情况下,EST后NIHSS评分的改善与卒中后死亡率降低相关,这意味着有净收益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号